PLx Pharma Inc.
PLXP
Price:
$0.087
Market Cap:
$2.53M
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores,...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-03-13
Stock Exchange
NASDAQ
Ticker
PLXP
The ROE as of September 2024 (TTM) for PLx Pharma Inc. (PLXP) is -165.64%
According to PLx Pharma Inc.’s latest financial reports and current stock price. The company's current ROE is -165.64%. This represents a change of 1.15% compared to the average of -13.22% of the last 4 quarters.
PLx Pharma Inc. (PLXP) Historical ROE (quarterly & annually)
How has PLXP ROE performed in the past?
The mean historical ROE of PLx Pharma Inc. over the last ten years is -244.42%. The current -165.64% ROE has changed -32.23% with respect to the historical average. Over the past ten years (40 quarters), PLXP's ROE was at its highest in in the June 2020 quarter at 205.94%. The ROE was at its lowest in in the June 2019 quarter at -2916.38%.
Average
-244.42%
Median
-133.24%
Minimum
-1359.51%
Maximum
13.91%
PLx Pharma Inc. (PLXP) ROE by Quarter and Year
Discovering the peaks and valleys of PLx Pharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 134.08%
Maximum Annual ROE = 13.91%
Minimum Annual Increase = -9872.77%
Minimum Annual ROE = -1359.51%
| Year | ROE | Change |
|---|---|---|
| 2021 | -99.57% | -31.08% |
| 2020 | -144.48% | -89.37% |
| 2019 | -1359.51% | -9872.77% |
| 2018 | 13.91% | -104.18% |
| 2017 | -332.44% | 133.40% |
| 2016 | -142.44% | 134.08% |
| 2015 | -60.85% | 16.27% |
| 2014 | -52.34% | -58.19% |
| 2013 | -125.18% | -11.40% |
PLx Pharma Inc. (PLXP) Average ROE
How has PLXP ROE performed in the past?
The current ROE of PLx Pharma Inc. (PLXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-534.52%
5-year avg
-384.42%
10-year avg
-244.42%
PLx Pharma Inc. (PLXP) ROE vs. Peers
How is PLXP’s ROE compared to its peers?
PLx Pharma Inc.’s ROE is greater than Biofrontera Inc. (-477.13%), greater than Guardion Health Sciences, Inc. (-71.26%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-217.58%), greater than Akanda Corp. (-543.35%), greater than China Pharma Holdings, Inc. (-60.19%), greater than Cann American Corp. (-80.83%), less than Acorda Therapeutics, Inc. (485.80%), greater than Kala Pharmaceuticals, Inc. (-396.03%), greater than Mallinckrodt plc (-117.04%), greater than Halo Collective Inc. (-234.02%), greater than Alimera Sciences, Inc. (-33.70%), greater than China SXT Pharmaceuticals, Inc. (-195.84%), greater than Petros Pharmaceuticals, Inc. (-134.64%), greater than Societal CDMO, Inc. (-23.37%), greater than Organogenesis Holdings Inc. (-2.77%), less than Lifecore Biomedical, Inc. (26.37%), less than OptiNose, Inc. (53.43%),
| Company | ROE | Market cap |
|---|---|---|
| -477.13% | $6.15M | |
| -71.26% | $17.02M | |
| -217.58% | $3.42M | |
| -543.35% | $2.11M | |
| -60.19% | $3.04M | |
| -80.83% | $1.26M | |
| 485.80% | $821.03K | |
| -396.03% | $27.65M | |
| -117.04% | $4.52M | |
| -234.02% | $895.00 | |
| -33.70% | $302.38M | |
| -195.84% | $1.99M | |
| -134.64% | $3.27M | |
| -23.37% | $116.13M | |
| -2.77% | $327.46M | |
| 26.37% | $147.38M | |
| 53.43% | $143.49M |
Build a custom stock screener for PLx Pharma Inc. (PLXP) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PLx Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
PLx Pharma Inc. (PLXP) and other stocks custom spreadsheet templates
The easiest way to analyze a company like PLx Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is PLx Pharma Inc.'s ROE?
How is the ROE calculated for PLx Pharma Inc. (PLXP)?
What is the highest ROE for PLx Pharma Inc. (PLXP)?
What is the 3-year average ROE for PLx Pharma Inc. (PLXP)?
What is the 5-year average ROE for PLx Pharma Inc. (PLXP)?
How does the current ROE for PLx Pharma Inc. (PLXP) compare to its historical average?